AOD 9604 (5mg)

AOD 9604 is a modified peptide fragment of human Growth Hormone (hGH), specifically the amino acid sequence 176-191 with an added tyrosine residue. It is designed to promote lipolysis—the breakdown of fats—without affecting insulin or IGF-1 levels, thus avoiding the glucose intolerance associated with full-length hGH.

AOD 9604 (5mg)

With a molecular formula of C78H123N23O23S2 and a weight of 1815.1 g/mol, this USA-synthesized peptide has been extensively studied in murine models for weight reduction by stimulating fatty acid release from adipose cells and increasing sensitivity to lipolytic signals.

Research also suggests potential applications in cartilage regeneration, where it may improve pain perception and mobility in arthritic joints, and in indirectly improving cardiac function by reducing obesity-related risks.